Select Publications
Conference Abstracts
2020, 'CANAGLIFLOZIN AND RISK OF GENITAL INFECTIONS AND URINARY TRACT INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE- A POST-HOC ANALYSIS OF THE CREDENCE TRIAL', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, Vol. 35, pp. 1336 - 1336, presented at 57th ERA-EDTA Congress, ELECTR NETWORK, 06 June 2020 - 09 June 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000562392101381&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, Vol. 35, pp. 1342 - 1342, presented at 57th ERA-EDTA Congress, ELECTR NETWORK, 06 June 2020 - 09 June 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000562392101387&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIFFERENT BASELINE LEVELS OF TYPE 2 DIABETES MELLITUS DISEASE SEVERITY: RESULTS FROM THE CANVAS PROGRAM', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, Vol. 35, pp. 1351 - 1351, presented at 57th ERA-EDTA Congress, ELECTR NETWORK, 06 June 2020 - 09 June 2020, http://dx.doi.org/10.1093/ndt/gfaa142|iii1351
,2020, 'CANAGLIFLOZIN (CANA) REDUCES CARDIOVASCULAR (CV) AND RENAL EVENTS INDEPENDENT OF BASELINE HEART FAILURE (HF): A CREDENCE SECONDARY ANALYSIS', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 75, pp. 1018 - 1018, presented at Conference of American-College-of-Cardiology (ACC) / World Congress of Cardiology (WCC), IL, Chicago, 28 March 2020 - 30 March 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000522979101006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'EFFECTS OF CANAGLIFLOZIN ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES BY BASELINE LOOP DIURETIC USE: DATA FROM THE CREDENCE TRIAL', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 75, pp. 1852 - 1852, presented at Conference of American-College-of-Cardiology (ACC) / World Congress of Cardiology (WCC), IL, Chicago, 28 March 2020 - 30 March 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000522979101839&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'EFFECTS OF CANAGLIFLOZIN ON STROKE IN THE CREDENCE TRIAL', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 75, pp. 215 - 215, presented at Conference of American-College-of-Cardiology (ACC) / World Congress of Cardiology (WCC), IL, Chicago, 28 March 2020 - 30 March 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000522979100211&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'SUN-119 COMPARING SURVIVAL IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACROSS THREE COUNTRIES - RESULTS FROM THE STUDY OF HEART AND RENAL PROTECTION-EXTENDED REVIEW (SHARP-ER)', in Kidney International Reports, Elsevier BV, Vol. 5, pp. S250 - S250, http://dx.doi.org/10.1016/j.ekir.2020.02.646
,2019, 'Canagliflozin in patients with type 2 diabetes and macroalbuminuria: data from the CANVAS program', in DIABETOLOGIA, SPRINGER, SPAIN, Barcelona, Vol. 62, pp. S341 - S342, presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SPAIN, Barcelona, 16 September 2019 - 20 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303803041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, '1129-P: Association between the Intensity of Diabetes Therapy, Achieved HbA1c, and Persistence', in Diabetes, American Diabetes Association, CA, San Francisco, Vol. 68, presented at 79th Scientific Sessions of the American-Diabetes-Association (ADA), CA, San Francisco, 07 June 2019 - 11 June 2019, http://dx.doi.org/10.2337/db19-1129-p
,2019, '1130-P: Temporal Trends in Pharmacotherapy for Diabetes', in Diabetes, American Diabetes Association, CA, San Francisco, Vol. 68, presented at 79th Scientific Sessions of the American-Diabetes-Association (ADA), CA, San Francisco, 07 June 2019 - 11 June 2019, http://dx.doi.org/10.2337/db19-1130-p
,2018, 'FACTORS ASSOCIATED WITH REGRESSION OF LEFT VENTRICULAR MASS INDEX IN THE ACTIVE DIALYSIS TRIAL', in NEPHROLOGY, WILEY, Vol. 23, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'IMPACT OF DIETARY SODIUM REDUCTION ON ESTIMATED GLOMERULAR FILTRATION RATE IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS', in NEPHROLOGY, WILEY, Vol. 23, pp. 43 - 43, presented at Australian and New Zealand Society of Nephrology., http://dx.doi.org/10.26190/unsworks/28692
,2018, 'IMPACT OF EXTENDED HOURS DIALYSIS ON UTILITY-BASED QUALITY OF LIFE: RESULTS FROM THE ACTIVE DIALYSIS TRIAL', in NEPHROLOGY, WILEY, Vol. 23, pp. 11 - 12, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'INFECTION-RELATED HOSPITALISATIONS ACROSS DIFFERENT LEVELS OF KIDNEY FUNCTION: DATA FROM THE EXTEND45 STUDY', in NEPHROLOGY, WILEY, Vol. 23, pp. 40 - 40
,2018, 'KIDNEY FUNCTION, GLUCOSE-LOWERING TREATMENT AND HBA1C LEVELS IN PEOPLE WITH PREVALENT DIABETES: A POPULATION-BASED COHORT STUDY (EXTEND45)', in NEPHROLOGY, WILEY, Vol. 23, pp. 38 - 38
,2018, 'RELATIVE CONTRIBUTIONS TO MAJOR DIALYSIS RANDOMISED CONTROLLED TRIALS FROM TEN GLOBAL REGIONS', in NEPHROLOGY, WILEY, Vol. 23, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'THE QUALITY OF LIFE IMPROVEMENTS ASSOCIATED WITH EXTENDED HOURS DIALYSIS ARE CONSISTENT ACROSS SUBGROUPS', in NEPHROLOGY, WILEY, Vol. 23, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'CARDIOVASCULAR EVENTS IN A LINKED DATA COHORT OF DIALYSIS PATIENTS: IMPACT OF MODALITY AND EVENT DEFINITION', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, DENMARK, Copenhagen, Vol. 33, pp. 211 - 211, presented at 55th Congress of the European-Renal-Association (ERA) and European-Dialysis-and-Transplantation-Association (EDTA), DENMARK, Copenhagen, 24 May 2018 - 27 May 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000433059800573&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'PROGNOSTIC SIGNIFICANCE OF LOW LEVEL OF BLOOD GLUCOSE IN SEVERE ACUTE KIDNEY INJURY: A SECONDARY ANALYSIS FROM THE RENAL STUDY', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, DENMARK, Copenhagen, Vol. 33, presented at 55th Congress of the European-Renal-Association (ERA) and European-Dialysis-and-Transplantation-Association (EDTA), DENMARK, Copenhagen, 24 May 2018 - 27 May 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000433059801363&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES: A SYSTEMATIC REVIEWAND META-ANALYSIS', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 108 - 108, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383590600147&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Risk of major renal events in people with type 2 diabetes: prediction models based on the ADVANCE study population', in DIABETOLOGIA, SPRINGER, PORTUGAL, Lisbon, Vol. 54, pp. S442 - S442, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), PORTUGAL, Lisbon, 12 September 2011 - 16 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307671302285&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'NEW MODELS FOR THE PREDICTION OF EARLY AND LATE RENAL EVENTS IN TYPE 2 DIABETES', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 16, pp. 61 - 61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294977600144&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Preprints
2023, Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care, http://dx.doi.org/10.1101/2023.06.26.23291881
,2023, The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset, http://dx.doi.org/10.1101/2023.06.18.23290762
,2021, Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial, http://dx.doi.org/10.1101/2021.08.17.21262196
,Comparative Effectiveness of SGLT2i Versus DPP4i on Cardiovascular, Kidney and Hyperkalemia Outcomes in Individuals from Routine Clinical Practice: Observational Cohort Study, http://dx.doi.org/10.2139/ssrn.3947641
,Comparative Effectiveness of SGLT2i Versus GLP1-RA on Cardiovascular Outcomes in Routine Clinical Practice, http://dx.doi.org/10.2139/ssrn.3947642
,